Published: 03:53 PM, 22 June 2026 Last Update: 03:54 PM, 22 June 2026
India's pharmaceutical support: A lifeline for Africa's vaccine challenges
A Uganda Red Cross Society worker in protective gear is sprayed with disinfectant during the evacuation of the body of a suspected Ebola victim. (Image: AFP)
The recent postponement of the India-Africa Forum Summit IV, originally scheduled for May 28–31 in New Delhi, has cast a significant light on continental diplomacy and high-level engagement between India and African nations.
The joint decision by India and the African Union, announced just days before the event, cited the “emerging public health situation” on the continent, widely understood to refer to the ongoing Bundibugyo ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda, raising concerns about the safety and full participation of African leaders and delegates.
Official statements remained cautious, but wider speculation pointed directly to fears of the virus spreading among attendees.
While the postponement of the India-Africa Forum Summit due to Ebola fears disrupted high-level talks, it simultaneously spotlighted India’s decisive role in fast-tracking the critical production of a vaccine via the Serum Institute of India (SII), positioning New Delhi as an indispensable partner which has made urgent and swift interventions.
India’s role mirrors its Covid-19 response, where SII emerged as the world’s vaccine powerhouse, producing billions of doses affordably for the Global South in particular, Africa. During Covid-19, SII supplied much of the developing world with vaccines, often at cost or low margins.
Now, through CEPI partnerships with Oxford and African stakeholders, it enables rapid scaling for this rarer Ebola species first identified in 2007. Bloomberg and related reports have detailed that SII is leveraging its proven ChAdOx1 technology to fast-track clinical-grade doses, potentially ready for trials in two to three months.
This swift intervention positions India as a reliable big brother to Africa, prioritising affordable access for affected nations while working closely with African counterparts on trial preparedness and distribution planning.
The South African Government has already donated over $2.5m to the Ebola outbreak while South African regulators and institutions stand ready to support evaluations, building on Covid-19-era lessons of collaboration.
The African Union (AU) coordinates via Africa Centres for Disease Control, declaring a Public Health Emergency and pushing for vaccines by year’s end. However, core R&D and manufacturing for this candidate originate externally.
African scientists contribute expertise, but end-to-end sovereignty remains limited by funding, infrastructure, and regulatory hurdles. South Africa’s manufacturing hub status has not translated into independent leadership on this strain, echoing broader challenges. Africa, particularly the African Union, still relies heavily on external factors to produce its own vaccines.
India’s support extends beyond vaccines. Recent donations of rice, 1 000 metric tons to Burkina Faso for vulnerable communities and internally displaced persons, plus aid to Malawi and Mozambique, demonstrate comprehensive solidarity with Africa amid food insecurity compounded by conflicts and climate challenges in the continent.
Partnerships with India, CEPI, Oxford, and others are vital bridges, but true self-reliance demands sustained investment in local biotech, technology transfer, and unified regulatory frameworks. Until then, crises like this Bundibugyo outbreak will continue to expose dependencies, even as partners like India demonstrate goodwill.
In conclusion, the African Union (AU) and member states, including South Africa, still depend significantly on external expertise and manufacturing.
India’s consistent support offers both immediate relief and a blueprint for what deeper African-led capacity could achieve. The postponed India-Africa summit offers a moment for reflection: strengthening AU-led capacity must match the urgency of India’s actions.
Written by: Phapano Phasha (The author is the chairperson of The Centre for Alternative Political and Economic Thought.)
>> Source: IOL
